Eximis Surgical develops an enabling technology that allows surgeons to quickly remove large specimens through small incisions.
Eximis Surgical has raised $15.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.
Eximis Surgical's investors include Questa Capital Management, Venture Investors, Olympus, MedTech Innovator, ForMED Ventures.
Eximis Surgical is headquartered in Louisville, United States.
Eximis Surgical develops an enabling technology that allows surgeons to quickly remove large specimens through small incisions.
Eximis Surgical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eximis Surgical — Funding & Investors." VCBacked, April 24, 2023, https://www.vcbacked.co/company/eximis-surgical. Accessed July 23, 2026.
VCBacked. (2023). Eximis Surgical — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/eximis-surgical
{{cite web |title=Eximis Surgical — Funding & Investors |url=https://www.vcbacked.co/company/eximis-surgical |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated